Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study
Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0279147-e0279147
Open Access | Times Cited: 12
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14965-14965
Open Access | Times Cited: 12
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Nickolay A. Kryuchkov, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 326-326
Open Access | Times Cited: 10
An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement
Vinícius Pinto Costa Rocha, Helenita Costa Quadros, Antônio Márcio Santana Fernandes, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1504-1504
Open Access | Times Cited: 8
Editorial: COVID-19 booster vaccination: increasing immunity against life-threatening infection
Ritthideach Yorsaeng, Kamolthip Atsawawaranunt, Abanoub Riad
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2
Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study
Joshua Nazareth, Christopher Martin, Daniel Pan, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 101022-101022
Open Access | Times Cited: 2
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 570-570
Open Access | Times Cited: 6
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration
Germain Simon, Julien Favresse, Constant Gillot, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 10, pp. 1875-1885
Open Access | Times Cited: 6
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine
Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1613-1613
Open Access | Times Cited: 10
Determinants of Antibody Levels and Protection against Omicron BQ.1/XBB Breakthrough Infection
Carla Martín Pérez, Anna Ramírez‐Morros, Alfons Jiménez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: Safety and immunogenicity to Omicron BA.4/BA.5
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients
Ahram Han, Sangil Min, Eun-Ah Jo, et al.
Annals of Laboratory Medicine (2023) Vol. 44, Iss. 1, pp. 64-73
Open Access | Times Cited: 4
Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review
Renate Hausinger, Quirin Bachmann, Timotius Crone-Rawe, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 863-863
Open Access | Times Cited: 2
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains
Al Nasar Ahmed Sehgal, Jera Safran, Bernhard Kratzer, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 377-377
Open Access
Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
Porntip Intapiboon, Nawamin Pinpathomrat, Siriporn Juthong, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 537-537
Open Access | Times Cited: 1
Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
Anussara Prayongrat, Patjaya Noppaving, Thitiporn Chobarporn, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1135-1135
Open Access | Times Cited: 1
Page 1

Scroll to top